Article
An assessment of the genetic toxicology of novel boron‐containing therapeutic agents
26 Apr 2013
Abstract excerpt
Boron-containing compounds are being studied as potential therapeutic agents. As part of the safety assessment of these therapeutic agents, a battery of genetic toxicology studies was conducted. The battery included a bacterial reverse mutation (Ames) assay, an in vitro chromosome aberration assay in peripheral human lymphocytes, and an in vivo rat micronucleus study. The following compounds represent some of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
